Blog

10 Feb Update: Where Things Stand on the 340B Rebate Pilot

Posted at 11:34 AM in Uncategorized by Peta Russell

We want to share a brief update on developments since our last communication regarding the federal court’s decision to halt HRSA’s 340B rebate pilot. The pause remains in effect. Following the December 29 court order blocking the rebate pilot from taking effect, HRSA formally paused implementation on...

13 Jan 340B Rebate Model Pilot: Temporary Restraining Order Issued

Posted at 12:20 PM in Uncategorized by Peta Russell

A major development has changed the near-term outlook for the 340B Rebate Model Pilot. On December 29, a federal district judge in Maine issued a temporary restraining order blocking HRSA from launching the 340B rebate pilot as planned on January 1. The order applies nationwide and...

19 Dec Beacon’s Final Data Validation Rules: What Will Get 340B Claims Accepted or Denied

Posted at 6:59 PM in Uncategorized by Peta Russell

Beacon has published the full Data Validations Overview, and this is the document that will determine whether rebate submissions are accepted or denied once the model goes live. It is the most detailed and definitive guidance Beacon has released to date, and several items differ from...

12 Dec Beacon Rebate Model: December Pulse Check and Key Updates to Know Before January 1

Posted at 6:42 PM in Uncategorized by Peta Russell

Below is your December pulse-check on all things Beacon and rebate. One more thing: Beacon quietly published its full Data Validations Overview, and it’s hefty. Watch for a separate update soon, we’ll walk you through what changed and what you may need to adjust before...

21 Nov

Posted at 9:31 AM in Uncategorized by Peta Russell

The Real Cost of the 340B Rebate Model: Why Cash Flow Planning Can’t Wait The 340B Rebate Model Pilot represents a major shift in how covered entities manage their pharmacy programs. Scheduled for January 1, 2026, certain high-cost drugs will no longer come with upfront 340B...

14 Nov Beacon Rebate Pilot – Week 1 Update

Posted at 11:59 AM in Uncategorized by Peta Russell

HRSA’s 340B Rebate Model pilot remains on schedule for January 1, 2026, despite the ongoing federal government shutdown. Beacon Channel Management has issued updated manufacturer guidance, revised its FAQ on November 3, and opened registration for all covered entities. Key Program Updates Implementation Date: January 1, 2026...

06 Nov 340B Rebate Model: What to Know for 2026

Posted at 12:12 PM in Uncategorized by Peta Russell

The 340B Program is facing one of its biggest structural shifts in decades. Potentially starting January 1, 2026, or closely thereafter, HRSA and CMS plan to launch the 340B Rebate Model Pilot, aligning it with Medicare’s Drug Price Negotiation Program (MDPNP) under the Inflation Reduction...

16 Oct Is Your 340B Program Audit-Ready? What Covered Entities Must Prepare for in 2025

Posted at 11:03 AM in Uncategorized by Peta Russell

The Audit Environment Is More Aggressive Than Ever HRSA and manufacturer audits of 340B programs are not slowing down in 2025, and covered entities continue to face increasing scrutiny. In some cases manufacturers have pursued their own. Whether you're a hospital, FQHC, or Ryan White clinic,...

08 Oct The Contract Pharmacy Dilemma: What 340B Covered Entities Need to Know in 2025

Posted at 11:00 AM in Uncategorized by Peta Russell

The Shifting Landscape In recent years, the 340B contract pharmacy landscape has been under intense pressure —and in 2025, covered entities are still navigating the fallout. Restrictions from manufacturers, lack of regulatory clarity, and growing scrutiny to justify program savings have left many organizations asking: “Should...

02 Oct The 340B Program in 2025: How Covered Entities Can Stay Compliant Amid Ongoing Scrutiny

Posted at 10:58 AM in Uncategorized by Peta Russell

If your organization participates in the 340B Drug Pricing Program, you’re likely feeling the pressure in 2025. Increased HRSA audit activity, manufacturers pushing for restrictions, and shifting contract pharmacy policies are challenging covered entities like never before. At Ponaman Healthcare Consulting, we work closely with covered...